Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review

Celiac disease (CD) is an autoimmune disorder of the gastrointestinal tract in a genetically susceptible person. Gluten is the most crucial trigger factor for CD, and environmental factors such as microbiota and opportunistic infection risk its pathogenesis. Coronavirus disease 19 (COVID-19) spread...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholam-Mostafaei, Fahimeh Sadat, Didari, Tina, Ramandi, Marzieh, Vafaee, Reza, Rostami-Nejad, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817746/
https://www.ncbi.nlm.nih.gov/pubmed/35154599
_version_ 1784645704031928320
author Gholam-Mostafaei, Fahimeh Sadat
Didari, Tina
Ramandi, Marzieh
Vafaee, Reza
Rostami-Nejad, Mohammad
author_facet Gholam-Mostafaei, Fahimeh Sadat
Didari, Tina
Ramandi, Marzieh
Vafaee, Reza
Rostami-Nejad, Mohammad
author_sort Gholam-Mostafaei, Fahimeh Sadat
collection PubMed
description Celiac disease (CD) is an autoimmune disorder of the gastrointestinal tract in a genetically susceptible person. Gluten is the most crucial trigger factor for CD, and environmental factors such as microbiota and opportunistic infection risk its pathogenesis. Coronavirus disease 19 (COVID-19) spread rapidly and became a problem for healthcare systems worldwide. Little is known about the risk of severe COVID-19 and the role of dysbiosis among patients with CD. There is also a lack of knowledge about the effects of CD gut microbiota on COVID-19 infection. Therefore, the current review discusses the relationship between CD and risk factors such as microbiota for susceptibility to COVID-19.
format Online
Article
Text
id pubmed-8817746
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-88177462022-02-11 Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review Gholam-Mostafaei, Fahimeh Sadat Didari, Tina Ramandi, Marzieh Vafaee, Reza Rostami-Nejad, Mohammad Gastroenterol Hepatol Bed Bench Review Article Celiac disease (CD) is an autoimmune disorder of the gastrointestinal tract in a genetically susceptible person. Gluten is the most crucial trigger factor for CD, and environmental factors such as microbiota and opportunistic infection risk its pathogenesis. Coronavirus disease 19 (COVID-19) spread rapidly and became a problem for healthcare systems worldwide. Little is known about the risk of severe COVID-19 and the role of dysbiosis among patients with CD. There is also a lack of knowledge about the effects of CD gut microbiota on COVID-19 infection. Therefore, the current review discusses the relationship between CD and risk factors such as microbiota for susceptibility to COVID-19. Shaheed Beheshti University of Medical Sciences 2021 /pmc/articles/PMC8817746/ /pubmed/35154599 Text en ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gholam-Mostafaei, Fahimeh Sadat
Didari, Tina
Ramandi, Marzieh
Vafaee, Reza
Rostami-Nejad, Mohammad
Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title_full Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title_fullStr Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title_full_unstemmed Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title_short Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
title_sort gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of covid-19 infection: a review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817746/
https://www.ncbi.nlm.nih.gov/pubmed/35154599
work_keys_str_mv AT gholammostafaeifahimehsadat gutmicrobiotaangiotensinconvertingenzymeceliacdiseaseandriskofcovid19infectionareview
AT didaritina gutmicrobiotaangiotensinconvertingenzymeceliacdiseaseandriskofcovid19infectionareview
AT ramandimarzieh gutmicrobiotaangiotensinconvertingenzymeceliacdiseaseandriskofcovid19infectionareview
AT vafaeereza gutmicrobiotaangiotensinconvertingenzymeceliacdiseaseandriskofcovid19infectionareview
AT rostaminejadmohammad gutmicrobiotaangiotensinconvertingenzymeceliacdiseaseandriskofcovid19infectionareview

Ejemplares similares